Time Is Short To Prepare For New Post-Brexit UK Regulation
Off-Patent Industry Reacts To Post-Transition Period Guidance From MHRA
Guidance from the UK’s MHRA on post-Brexit arrangements relevant to the off-patent industry has been welcomed by local industry body the BGMA. However, it has warned that time is short to prepare for the end of the UK-EU transition period, with new guidance in certain areas “critical.”
You may also be interested in...
Warwick Smith has stepped down as head of the British Generic Manufacturers Association and British Biosimilars Association, to be replaced by Mark Samuels as CEO.
Despite Brexit uncertainty and travel restrictions that have just been imposed on the UK, the country’s generics industry is not expected to suffer major disruptions.
The UK’s approach to pharmacovigilance system requirements in the post-Brexit transition period will allow companies to leverage some of the existing structures put in place for EU systems.